Arnold D. Rubin
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Immunology top 10%
- Toxin Mechanisms and Immunotoxins
- Immune Cell Function and Interaction
Papers in
- Genetics 7
- Chronic Lymphocytic Leukemia Research 5
-
- Hematopoietic Stem Cell Transplantation 4
- Acute Myeloid Leukemia Research 3
- Co-authors
- Herbert L. CooperWilliam DameshekK. HavemannSteven D. DouglasLawrence N. ChessinPhilip R. GladeLawrence C. SwayneGeorge Hajjar
- Journals
- Blood (5 papers)African Arts (3 papers)Cancer (2 papers)Clinical Cancer Research (1 paper)American Journal of Physiology-Legacy Content (1 paper)
- Partner nations
- United StatesSwitzerlandItaly
In The Last Decade
Arnold D. Rubin
28 papers receiving 752 citations
Peers
Comparison fields: 5 of 79
- Genetics 175
- Immunology 245
- Hematology 115
- Radiology, Nuclear Medicine and Imaging 157
- Biotechnology 43
Countries citing papers authored by Arnold D. Rubin
This map shows the geographic impact of Arnold D. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold D. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold D. Rubin more than expected).
Fields of papers citing papers by Arnold D. Rubin
This network shows the impact of papers produced by Arnold D. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold D. Rubin. The network helps show where Arnold D. Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnold D. Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 0 | |
| 2 | 2010 | 26 | |
| 3 | 2008 | 12 | |
| 4 | 2008 | 13 | |
| 5 | A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer. | 2005 | 39 |
| 6 | 2005 | 0 | |
| 7 | 2003 | 21 | |
| 8 | 2000 | 45 | |
| 9 | 1999 | 62 | |
| 10 | Importance of timing of radioimmunotherapy after granulocyte colony-stimulating factor administration for peripheral blood stem cell harvest. | 1999 | 4 |
| 11 | 1997 | 28 | |
| 12 | The Leukemia cell | 1979 | 1 |
| 13 | 1973 | 16 | |
| 14 | 1972 | 15 | |
| 15 | 1971 | 0 | |
| 16 | 1971 | 17 | |
| 17 | 1967 | 5 | |
| 18 | 1966 | 24 | |
| 19 | 1964 | 16 | |
| 20 | 1961 | 1 |
About Arnold D. Rubin
Arnold D. Rubin is a scholar working on Genetics, Hematology, Visual Arts and Performing Arts, Immunology and Pathology and Forensic Medicine, having authored 33 papers that have together received 848 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Acute Myeloid Leukemia Research (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Genetics (175 citations), Immunology (245 citations), Hematology (115 citations), Radiology, Nuclear Medicine and Imaging (157 citations) and Biotechnology (43 citations). Arnold D. Rubin has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Herbert L. Cooper, William Dameshek, K. Havemann, Steven D. Douglas, Lawrence N. Chessin, Philip R. Glade, Lawrence C. Swayne, George Hajjar, Malik E. Juweid and Michael A. Pereira. Their work appears in journals such as Blood, African Arts, Cancer, Clinical Cancer Research and American Journal of Physiology-Legacy Content.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.